Safety of Thrombolysis in Patients With Acute Ischemic Stroke and Cerebral Cavernous Malformations
Author(s) -
Hebun Erdur,
Jan F. Scheitz,
Serdar Tütüncü,
Jochen B. Fiebach,
Matthias Endres,
David J. Werring,
Christian H. Nolte
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.004559
Subject(s) - medicine , interquartile range , thrombolysis , intracerebral hemorrhage , stroke (engine) , intraparenchymal hemorrhage , surgery , subarachnoid hemorrhage , mechanical engineering , myocardial infarction , engineering
Data on safety of intravenous thrombolysis with recombinant tissue-type plasminogen activator for acute ischemic stroke in patients with coexisting cerebral cavernous malformations (CCMs) are scarce. We assessed the risk of thrombolysis-associated hemorrhage in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom